Cargando…

Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma

Liver hepatocellular carcinoma (LIHC) is the most prevalent primary cancer of the liver, and immune-related genes (IRGs) regulate its development. So far, there is still no precise biomarker that predicts response to immunotherapy in LIHC. Therefore, this research seeks to identify immunogenic progn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lei, Quan, Wen, Luo, Qiong, Pan, Ying, Peng, Dongxu, Zhang, Guihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542239/ https://www.ncbi.nlm.nih.gov/pubmed/33195412 http://dx.doi.org/10.3389/fmolb.2020.567950

Ejemplares similares

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma
por: Feng, Xiaofei, et al.
Publicado: (2021)

Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer
por: Wu, Lei, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Huang, Shenglan, et al.
Publicado: (2021)

Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
por: Gao, Qiannan, et al.
Publicado: (2022)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
por: Jin, Chen, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma
por: Zhang, Guangyuan, et al.
Publicado: (2021)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma
por: Li, Muqi, et al.
Publicado: (2020)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
por: Kumar, Vinay, et al.
Publicado: (2023)

RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma
por: Peng, Hao, et al.
Publicado: (2022)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Xing-Wei, et al.
Publicado: (2021)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Extracellular Matrix-Based Gene Expression Signature Defines Two Prognostic Subtypes of Hepatocellular Carcinoma With Different Immune Microenvironment Characteristics
por: Tang, Hui, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2021)

The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023)

Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma
por: Zhao, Enfa, et al.
Publicado: (2021)

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2021)

Cell Division Cycle Associated Genes as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2021)

A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Identification of a 3-Gene Prognostic Index for Papillary Thyroid Carcinoma
por: Zhong, Lin-Kun, et al.
Publicado: (2022)

BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis
por: Ju, Qiang, et al.
Publicado: (2020)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rte9cqgd7ffoegrp2k7re7ob2n